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Representing the most potent antigen-presenting cells, dendritic cells (DC) can now be generated
from human blood monocytes. We recently presented a novel protocol employing GM-CSF,
IL-4, and IFN-y to differentiate monocyte-derived DC in vitro. Here, such cells are characterized
in detail. Cells in culture exhibited both dendritic and veiled morphologies, the former being
adherent and the latter suspended. Phenotypically, they were CDla-/dim, CD1 a/, CD1 b++,
CDllc+, CD14dim/-, CD16a-/dim, CD18+, CD32dim/-, CD33+, CD40+, CD45R0+, CD50+,
CD54+, CD64-/dim, CD68+, CD71 +, CD80dim, CD86+/++, MHC class
++/+++ HLA-DR
++/+++
HLA-DP/, and HLA-DQ/. The DC stimulated a strong allogeneic T-cell response, and further
evidence for their autologous antigen-specific stimulation is discussed. Although resembling a
mature CD c/CD45R0 blood DC subset identified earlier, their differentiation in the presence
of the Thl and Th2 cytokines IFN-y and IL-4 indicates that these DC may conform to mature
mucosal DC.
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INTRODUCTION
We recently presented cumulative evidence for the
myelomonocytic origin of dendritic cells (DC) that
belong to the functional entity of professional anti-
gen-presenting cells (APC) (Peters et al., 1996).
Partly resolving the controversy on the ontogenetic
pathway of DC recruitment, there is now sufficient
proof for their differentiation from myeloid pre-
cursors. Accordingly, both DC or their migratory
counterparts expressing cytoplasmic veils, were gen-
erated in vitro both from myeloid-lineage-type bone
marrow precursors (Gieseler et al., 1991; Reid et al.,
1992; Santiago-Schwarz et al., 1992; Inaba et al.,
1993; Romani et al., 1994; Chen-Woan et al., 1996)
as well as late blood monocytes (Gieseler, 1987;
Peters et al., 1987; Kabel et al., 1989; Thomas et al.,
1993; Zhou and Tedder, 1996).
Thus, large numbers of DC can now be generated
from myelomonocytic progeny. It should be noted,
however, that this does not rule out the possible
differentiation of DC from nonmyeloid lineages
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(Steinman and Cohn, 1973; Steinman, 1991), perhaps
even common with T-cell progenitors (Ardavin et al.,
1993; O’Neill, 1994). Future studies will help to
classify such observations, which may, for the time
being, be regarded as hints toward the complex
regulation and integration of antigen specificity.
In any case, depending on the nature and composi-
tion of environmental stimuli, monocytes may be
induced to differentiate into either of the two major
classes of professional APC, that is, DC or macro-
phages (Mq) (Peters et al., 1991, 1996). Because DC
and Mq are crucial for directing the course of
immunity, the genetic program underlying their
developmental dichotomy is to be regarded as a major
cornerstone of immune regulation.
Moreover, as to the diverse conditions in the
various anatomic sites, local monocyte differentiation
should even result in a broad spectrum of phenotypes,
rather than only two idealized cell populations.
Indeed, this deduction has long been verified empiri-
cally, suggesting that the actual tissue shapes its
characteristic APC compartment (e.g., Franklin et al.,
1986). This is consistent with the finding that, for
example, DC obtained from spleen and Peyer’s
patches profoundly differ in their preferential activa-
tion of T-helper 1 (Thl) or Th2 cells (Everson et al.,
1996).
Studying the effect of growth factors and cytokines
on isolated monocytes thus appears suitable to
identify signals controlling the development of dis-
crete myeloid APC types. As to the thought pathway
sketched before, such molecules would induce basic
DC or Mq differentiation as well as fine-tune their
tissue-specific maturation. The past years then
brought about several culture systems for the genera-
tion of monocyte-derived DC (MoDC) in the presence
of selected factors (cf. Peters et al., 1996). One of the
generally accepted protocols employs a combination
of granulocyte-macrophage colony-stimulating factor
(GM-CSF) and interleukin-4 (IL-4), leading to CD la
and CD14- or CD14’im DC that are able to induce
mycobacterium- and tetanus-toxin-specific T-cell pro-
liferation, as well as mixed leukocyte responses
(Porcelli et al., 1992; Ruppert et al., 1993; Romani et
al., 1994; Sallusto and Lanzavecchia, 1994; Steinbach
et al., 1995; Kiertscher and Roth, 1996).
We then proceeded to question whether interferon y
(IFN-y), which upregulates the expression of major
histocompatibility complex (MHC) class II mole-
cules, might support the functionality of MoDC. This
working hypothesis could be verified when culturing
monocytes with GM-CSF, IL-4, and IFN-T, which
gave rise to DC strongly supporting a mixed leuko-
cyte reaction (Xu et al., 1995).
This paper now presents a phenotypic character-
ization of freshly isolated monocytes, and the MoDC
(including both DC and veiled cells) generated from
them by action of GM-CSF, IL-4, and IFN-y.
Specifically, we focused on the expression of mye-
loid-type markers, MHC class I and II antigens,
selected adhesion molecules, as well as antigens
delineating certain subsets and maturity stages of DC
in vivo. The resultant phenotypic profile now allows
to classify the ontogenetic root of such cells, to
pinpoint their stage of development and to discuss
their possible counterpart in vivo. Additional morpho-
logical and functional data underscore the mature
stage of the MoDC obtained with this culture
system.
RESULTS
Morphology and Differentiation of MoDC in
Culture
Monocytes cultured for 6 days in the presence ofGM-
CSF, IL-4, and IFN-y exhibited three principal
morphologies. The majority of cells (> 60%) weakly
adhered to the gas-permeable Teflon surface of the
culture flasks. These cells revealed numerous dend-
ritic projections and occasional veillike cytoplasmic
structures. Their general morphologic appearance
resembled that of Langerhans cells in situ.
Starting with the third day of culture, part of such
cells began to detach and gave rise to a second
population of suspended cells that, 1 to 2 days later,
plateaued at --30% of the total cell number. These
nonadherent cells had ovoid, bluntly branched cell
bodies exhibiting abundant cytoplasmic veils. VeilGENERATION OF MATURE HUMAN DC 27
structures appeared to mainly bud from such projec-
tions (Figure 1), which may correspond to the
dendritiform ramifications during the adherent cell
stage.
Third, we observed a small proportion of--5%
strongly adherent Mq. The majority of these cells
were stretched in shape with a broad footlike
projection on one of the cell poles. M q) were larger
than dendritic and veiled cells and, unlike these,
exhibited abundant perinuclear lysosomes and occa-
sional vacuolization. These Mq revealed some very
interesting features deserving special consideration
and are presented in detail elsewhere (Gieseler et al.,
1998).
The Phenotype of MoDC
Depending on their mean fluorescence intensities
(AMFI; see Materials and Methods), we here defined
the expression of markers as dim (AMFI 10-100), +
(AMFI > 100-1000), ++ (AMFI > 1000-5000) or +++
(AMFI > 5000).
b
FIGURE Scanning electron micrographs of veiled cells derived
from blood monocytes. Veiled cells were collected from super-
natants of cells cultured for 6 days in the presence of GM-CSF, IL-
4, and IFN-% and processed as indicated. (a) Several cells
immobilized on poly-L-lysine exhibit a spectrum of veil structures
and cytoplasmic processes. Original magnification 1500. The bar
represents 10/xm. (b) The typical appearance of a suspended cell in
culture conforms to blood dendritic cells (Knight et al., 1986) or
veiled cells from afferent lymph (Barfoot et al., 1989) or colonic
lamina propria (Pavli et al., 1993). Original magnification 3000.
The bar indicates 5/xm.
Myeloid Antigens
Cultured cells did not proliferate, that is, they did not
form clones or incorporate [3H]thymidine (not
shown). Hence, DC and veiled cells generated in the
presence of cytokines clearly were descendants of
monocytes, as shown by their expression of the
myeloid lineage marker CD33 (throughout the mye-
loid life cycle) as well as CD68 (Figure 2). Though
often being considered a Mq>specific marker, CD68
may also be expressed by DC (Beelen et al., 1993).
However, CD68 expression on MoDC was lower
than that observed on serum-culturedMq (Figures 2B
and 2C). Another marker still regarded as a hall-
mark of Mq is CD14, that is, the receptor for
complexes of LPS/LPS-binding protein. Yet, in vivo,
DC in distinct sites, such as mucosal tissue, may well
express CD14, as was shown by Graeme-Cook et al.
(1993). Therefore, supposing a common origin ofDC
and Mq, CD68 and CD14 may be subject to
exogenous environmental regulation in either of these
populations and their site-specific subsets. Earlier,
Thomas et al. (1993) showed that blood DC are
CD 14dimCD33bright. Accordingly, in confirming and
extending results from Ruppert et al., (1993), Sallusto
and Lanzavecchia (1994) as well as Kiertscher and28 R. GIESELER et al.
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FIGURE 2 Expression of myeloid antigens as determined by flow cytometry. The panel compares antigen expression by monocytes (row
A), monocytes cultured for 6 days with serum alone (row B), and DC and veiled cells derived from monocytes by action of GM-CSF/
IL-4/IFN-y (row C). The mAb are detailed in Table I. Each graph is representative of four to six experiments carried out. Histograms depict
the number of cells (maximal scaling equals to 200 cells) exhibiting various fluorescence intensities (AMFI) with either control mAb (bold
lines on the left) or tested antigens (faint lines). Percentages of antigen-positive cells in Fig. 6 were calculated from these data using the C30
program.
Roth (1996) obtained with GM-CSF and IL-4, we
here show complete downregulation of CD14 on
28.4% of MoDC as well as a CD14m phenotype of
the remaining cells (Figure 2C). Also, the Fcy
receptors (FcR) type I, II, and IIIA (CD64, CD32,
CD16a) were found downregulated. Very faint
expression of CD16 and CD64 (Figure 2C) by 33.9%
or 24.6% of cells (Figure 6) cultured with GM-CSF/
IL-4/IFN-y was partly due to the small Mq sub-
population that coemerged from the starter monocytes
(see earlier), and some of the MoDC, but not the
veiled cells. An interesting result was the CD32m
expression in 78.4% of cells (Figures 2C and 6),
because this conforms to blood DC expressing the
maturity marker CD83 (Zhou and Tedder, 1995). The
remaining cells were CD32-. Thus, according to the
preceding definition, the myeloid antigen pattern
detected on MoDC generated in the presence of GM-
CSF, IL-4, and IFN-y was CD14’m/-, CD16a-mm,
CD32m/-, CD33+, CD64-/m, and CD68/. Double
statements indicate the expression by different stages
of maturity, with the major portion mentioned first
and the minor portion in the second position.
DC and Maturation Antigens
Certain populations of DC or subsets thereof can be
discerned by several markers. The most prominent
may be CDla, which is expressed on immature
epidermal Langerhans cells, but becomes abrogated
when the cells drain to the lymph nodes and mature.
Here, 9.0-32.6% of MoDC were CDla’im (Figures 6
and 3C). We did not follow CDla expression during
the previous days of culture. However, judging from
the maturity markers determined in this study, the
majority ofMoDC cultured for 6 days appear to be in
a mature state that, therefore, does not conflict with
the loss of CDla. Two of such markers are the
integrin Cx-chain CD1 lc and CD45R0 a splicing
variant of the leukocyte common antigen. CD45R0 is
not only expressed by activated or memory T and B
cells, but also by mature blood DC (Zhou and Tedder,
1995) as well as DC differentiated from monocytes in
the presence of GM-CSF, IL-4, and tumor necrosis
factor c (TNF-c0 (Zhou and Tedder, 1996). In 1994,
O’Doherty et al. (1993) showed that a subpopulation
of blood DC express both, CDllc and CD45R0,
which reasonably is taken as circumstantial evidenceGENERATION OF MATURE HUMAN DC 29
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FIGURE 3 Expression of markers delineating subsets of DC, mature stages of DC differentiation, and cell activation. All specifications
are as given in the caption to Figure 2.
for their mature stage--even more so, when bearing
in mind that isolated blood DC, when cultured,
reveal a CD1 lc+CD45R0 phenotype. Approaching
almost 100% of cultured cells, the MoDC generated
in this present study were also CDllc+CD45R0
double-positive (Figures 3C and 6). One further
antigen clearly expressed by DC, but only weakly by
monocytes, is the B-cell marker CD40 (e.g., Zhou
and Tedder, 1995 and 1996). Here, almost 100% of
MoDC were CD40 (Figures 3C and 6). Further,
Andreesen et al. (1984) showed that CD71, a
receptor for complexes of Fe/transferritin, is
expressed depending on the degree of myelomono-
cytic differentiation. We have therefore chosen this
marker as additional proof for a mature stage of the
MoDC. As opposed to only marginal expression of
CD71 by low numbers of fresh monocytes, close to
100% of the MoDC, and veiled cells were strongly
positive for this receptor (Figures 3 and 6). The total
status of antigens chosen as markers of DC subsets,
as well as the degree of maturity and activation of
MoDC was CD 1a-/dim, CD 11c+, CD40+, CD45R0+,
and CD71+.
Antigen-presenting and Costimulatory Molecules
Gene products encoded by the MHC are prerequisite
for the effective presentation of processed antigen.
Brooks and Moore (1988) showed that HLA-DR,
-DP, and-DQ are strongly expressed by blood DC,
whereas monocytes are only weakly positive for class
II products of the DP and DQ subloci. We here
confirmed this finding for freshly isolated monocytes
(Figure 4A), and cells cultured with GM-CSF, IL-4,
and IFN-y exhibited a class-II phenotype similar to
that observed with blood DC (Figure 4C). Also,
although culture may lead to the expression of higher
levels of HLA-DP and-DQ (Brooks and Moore,
1988, and Figure 4B), the percentages of monocytes
positive for these gene products were evidently lower
than those detected with the MoDC, of which
virtually all cells coexpressed HLA-DR,-DP, and
-DQ (Figure 6). Importantly, veiled cells suspended in
culture expressed even higher amounts of HLA-DR
and -DP, that is, a peak of strong DR expression on
the far right of the histogram, and a shoulder of DP
expression at AMFI --700 (Figure 4C). Similarly, the
expression ofMHC class I (HLA-A,-B,-C) strongly30 R. GIESELER et al.
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FIGURE 4 Flow-cytometric detection of MHC class and class II as well as of costimulatory molecules. In a portion of GM-CSF/
IL-4/IFN-y cells (row C), MHC class and HLA-DR expression exceeded the logarithmic AMFI scale (i.e., >10000). These cells form
seperate peaks that accumulate on the far right of the histograms. All specifications are as given for Fig. 2.
increased with the time of culture (Figure 4). Since it
is known now that class I molecules not only serve to
present endogenous products but also may participate
in the presentation of exogenous antigens by Mq and
DC populations (Rock et al., 1993), an increase in
class I obviously may augment the APC’s antigen-
presenting capacity. Moreover, paralleling the obser-
vations for class II, veiled cells revealed extremely
upregulated class I expression, as reflected on the far
right of the AMFI log scale (Figure 4C). Therefore, in
strongly expressing MHC products, such cells qualify
as potent APC. This is further underscored by the
upregulation of costimulatory molecules B7.1 (CD80)
and B7.2 (CD86) on MoDC, as compared to their
starting population, or to cells cultured without
cytokines (Figure 4). While being absent from
immature DC (McLellan et al., 1995), the maturation
of DC implies upregulation of CD86 as primary and
CD80 as secondary costimulatory molecules to inter-
act with their T-cell ligands CD28 or CTLA-4.
Regular T-cell activation depends on these inter-
actions, for their absence leads to anergy or apoptosis
of the T cells involved (McLellan et al., 1995;
Thompson, 1995). The breadth of the peak for CD86
indicates that, at this point of time, MoDC at least
reach the B7.2-dependent stage of maturity (Figure
4C). As will be shown in what follows, such cells are
potent stimulators of an allogeneic mixed-leukocyte
reaction, whereas it is characteristic for immature DC
that they are quiescent. Taken together, the MHC/
costimulator phenotype of MoDC was MHC class
i++/+++, HLA_DR++/+++, HLA-DP HLA-DQ
CO80dim (but stronger than on Mqg, and CD86+/++.
Adhesion Molecules
To conclude phenotypic characterization, we selected
adhesion molecules, which, similar to B7.1 and B7.2,
are essential for the successful stimulation of antigen-
specific T cells by APC. Consistently, the Ig super-
family adhesion molecules CDlla (cL-chain) and
CDllb (cM-chain), the /-chain CD18, as well as
intercellular adhesion molecules (ICAM) (CD54)
and 3 (CD50) were all upregulated and expressed by
-90-100% of all MoDC Figures 5C and 6). As to
CD 1 lb, this molecule not only is a receptor for C3bi.
For whereas CD1 a and CD18 constitute the leuko-
cyte function-associated molecule (LFA- 1), CD11b
and CD18 can similarly associate as Mac-1. Both
LFA-1 and Mac-1 may compete for interaction with
ICAM-1 (Lub et al., 1996). We therefore will not
speculate at the present time which function(s) ofGENERATION OF MATURE HUMAN DC 31
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FIGURE 5 Cellular expression of selected adhesion molecules. For specifications, see above.
CD b may be utilized by DC. However, it has been
shown that cM-chains are expressed by subpopula-
tions of DC (Franklin et al., 1986; Robinson et al.,
1986), and not exclusively by M q). Interestingly,
ICAM-1 appears to be involved in DC migration and
late DC-dependent T-cell stimulation (Starling et al.,
1995). Therefore, this molecule may play a special
role for mature DC, which would complement the
previous picture. Indeed, ICAM-1 was found
expressed by MoDC, and its broadened peak indicates
different membrane densities of CD54 in the less
mature DC and the more mature veiled cells. The
pattern of selected adhesion molecules on MoDC was
CD 11a+, CD11b++, CD18+, CD50+, and CD54+.
The Functional Capacity of MoDC
To test the APC’s potency to induce allospecific
stimulation, we ran one-way mixed leukocyte cultures
(MLC). Of the MoDC, both their adherent DC and
suspended veiled-cell subsets were transferred into
microwells and cocultured with pools of T lympho-
cytes. We observed the clustering of MoDC and T
cells, as is typical of mature lymphoid DC (Austyn,
1987). MoDC induced a very vigorous proliferation
of allogeneic T cells, which was not the case with
fresh monocytes as stimulator cells (Figure 7). These
data complement those presented in our previous
study (Xu et al., 1995). Also, we recently were able to
show thatMoDC generated by action of GM-CSF, IL-
4, and IFN-y are as well able to stimulate autologous
antigen-specific T-cell proliferation (Soruri et al.,
1998).
DISCUSSION
The present study shows that DC and veiled cells can be
generated from blood monocytes in the presence of
GM-CSF, IL-4, and IFN-y. Phenotypically, such cells
are CDla-mim, CDlla+, CDllb++, CDllc+, CD14dm/-,
CD16a-/dim, CD18+, CD32ainu-, CD33+, CD40+,
CD45R0+, CD50+, CD54+, CD64-/dim, CD68+, CD71 +,
CDS0dim, CD86+/++, MHC class I++/+++, HLA-DR++/+++,
HLA-DP+, and HLA-DQ+. Specifically, the nonadher-
ent cells exhibited morphologies that strongly resem-
bled veiled-cell types that are in transit to, or encoun-
tered within, lymphoid tissues (examples are given in32 R. GIESELER et al.
Knight et al., 1986; Barfoot et al., 1989; and Pavli et al.,
1993).
It is consistent with previous results that these
MoDCmand, above all, the veiled cells--morpho-
logically, phenotypically, and functionally represent a
mature stage of differentiation. Irrespective of the cell
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FIGURE 6 Percentages of antigen-positive cells. Data of fresh
monocytes (empty bars) and cells cultured in the presence of GM-
CSF/IL-4/IFN-y (solid bars) are given as means, with error bars
indicating maxima and minima among the donors (n 4 to 6).
lineage, CD45R0 is only expressed by activated or
memory-type immunocytes. O’Doherty et al. (1993)
were the first to show maturation of isolated bloodDC
into CD45R0 cells. They concluded that the highly
stimulatory CD1 lc+CD45R0 double-positive blood
DC subset represents antigen-primed mature DC,
which are possibly en route to lymphoid organs, while
the less active CD1 lc-CD45R0- subset apparently
comprises immature blood DC (O’Doherty et al.,
1994). Similarly, in addition to demonstrating thatDC
generated by action of GM-CSF, IL-4, and IFN-y are
potent stimulators of allogeneic mixed leukocyte
80
’20 ’40 :80 ’60 :320
Stimulator Responder Ratio
FIGURE 7 MoDC are potent stimulators of an allogeneic mixed-
leukocyte reaction. Graded numbers (6.25 10 to 104) of
fresh monocytes or MoDC generated by action of GM-CSF/IL-
4/IFN-y were coincubated with 2 105 allogeneic T cells. As
opposed to monocytes (broken line, means and open symbols), the
MoDC (solid line, means and closed symbols) were potent
stimulator cells (n 5). T-cell controls revealed baseline incorpora-
tion of [3H] thymidine (315 dpm). APC controls did not proliferate
in any of the experiments. Consistent to all experiments, Mq only
stimulated marginally at a stimulator:responder ratio of 1:160 (529
dpm), and ceased to provoke T-cell proliferation at 1:320 (231
dpm).GENERATION OF MATURE HUMAN DC 33
reactions (Xu et al., 1995), we now show that such
cells coexpress CD45R0 and CD11 c. Another feature
identifying mature DC is their CD14dimCD33brigtt
phenotype, as opposed to functionally immature
CD14dimCD33oim DC (Thomas et al., 1993; Thomas
and Lipsky, 1994). Likewise, DC derived from
monocytes under GM-CSF, IL-4 and IFN-T were
CD14im/-CD33+.
Zhou and Tedder (1995) showed that CD14
monocytes, when cultured with GM-CSF, IL-4, and
TNF-ce, develop into CD83 DC. CD83 belongs to the
immunoglobulin superfamily and is distinctive for
mature blood DC. Of interest, in the absence of
proliferation, the yield of these MoDC was similar to
the number of monocytes cultured (Zhou and Tedder,
1996), which corroborates previous results (Peters et
al., 1991), and is in line with the fact that bone-
marrow precursors must pass a transient monocyte
stage before acquiring DC characteristics (Gieseler et
al., 1991). It was also observed that prolonged culture
of MoDC leads to their transition into large, round
Mq-like cells (Zhou and Tedder, 1996). This matches
the finding that highly stimulatory DC, as derived
from human monocytes in the presence of a placental
medium supplement, can be triggered to develop into
Mq by action of M-CSF, whereby accessory activity
is completely abrogated from such cultures (Gieseler,
1987). A serial monocyte DC Mq transition
could as well be achieved by the addition of serum to
human or rat DC derived from myeloid precursors
(Gieseler, 1987; Najar et al., 1990; Gieseler et al.,
1991; Peters et al., 1991).
As to their course of differentiation, DC generated
in the presence of GM-CSF, IL-4, and TNF-ce first
downregulate CD14, then become CDla+, again
downregulate CDla, and eventually express CD83.
At this stage, the MoDC additionally acquire CD45R0
(Zhou and Tedder, 1996). Hence, cells differentiated
with this cytokine mix reveal a transient CDla
Langerhans cell phenotype and further proceed to
develop into a mature interdigitating DC type.
Similarly, a mature DC phenotype, which may
delineate cells in transit to or present within lymphoid
organs, can also be induced with a cytokine cocktail
employing GM-CSF, IL-4, and IFN-T. Whether these
cells express CD83 is currently investigated (CD83-
specific mAb was kindly provided by F. Tedder, Duke
University Medical Center, Durham, NC). First
preliminary results indicate that they start to acquire
CD83 on the sixth day of culture.
Do these MoDC relate to Langerhans cells? In vivo,
skin DC express Mac-1 as well as Fc receptors
(Steinman, 1991). Functionally, Mac- 1 competes with
LFA-1 to interact with ICAM-1 (Lub et al., 1996),
which obviously plays a regulatory role in cell
cooperation, and the Fc receptors may actively
participate in the phagocytosis of antigens--a func-
tion clearly demonstrated for Langerhans cells (Reis e
Sousa et al., 1993). These markers were likewise
detected on the MoDC. That FcR were found
downregulated indicates the MoDC’s progression
from immature cells that take up antigen to matured
cells that may present processed antigenic material.
This notion is not only supported by the parallel
upregulation of MHC and costimulatory molecules,
but also by the observation that such cells induce
antigen-specific T-cell responses (Soruri et al., 1998).
Another indication may be their CDla
-/im status.
Yet, there is a further interpretation that results from
the microenvironment mimicked by Thl and Th2
cytokines IFN-y and IL-4. Langerhanslike cells are
not only present in skin, but also throughout mucosa-
associated lymphoid tissue. Interestingly, enteric
immune compartment provides a unique environment
where the low-density subsets of both ce//3-TCR and
T/6-TCR intraepithelial lymphocytes spontaneously
produce the Thl mediator IFN-T (Yamamoto et al.,
1993), whereas DC from Peyer’s patches pre-
dominantly induce the production of Th2 cytokines
such as IL-4 (Everson et al., 1996). We therefore
suggest that monocyte-derived cells obtained by
action of GM-CSF, IL-4, and IFN-y may resemble
mucosal enteric DC. The retention of low amounts of
CD32 FcyR II) on these cells, as opposed to human
colonic DC in situ (Pavli et al., 1993), may well be
due to the low concentration of cytokines employed.
We currently address this issue in our experiments.
Most interestingly, and in contrast to epidermal
Langerhans cells, DC freshly isolated from the
colonic lamina propria are potent MLR stimulators34 R. GIESELER et al.
(Pavli et al., 1993). This feature identifies mucosal
Langerhanslike cells as mature DC and is in line with
their CDla-negative phenotype (Graeme-Cook et al.,
1993). It therefore is suggested that the mucosal-
based lymphoid tissue functions as a genuine lym-
phoid organ that directly borders to the outer world.
That microenvironmental conditions imprint on the
local cells’ character is vividly demonstrated by
experiments employing GM-CSF. This factor not
only supports the differentiation of DC from mono-
cytic precursors; it also effects the functional matura-
tion of immature DC. Accordingly, GM-CSF induces
isolated skin Langerhans cells to stimulate an immune
response (Witmer-Pack et al., 1987), whereas, in
contrast to this, liver-derived immature DC are
induced to mature into tolerogenizing DC (Rastellini
et al., 1995). Therefore, the functional repertory
initiated by GM-CSF (and, probably, other factors) on
terminal DC maturation obviously depends on the
microenvironmental conditions shaping their imma-
ture precursors.
Correspondingly, to provide artificial microenvir-
onments in vitro may allow to mimick conditions
encountered in discrete tissues and has the potential to
generate site-specific (and functionally diverse) DC
subsets. Should the MoDC described in this study
approximate to mucosal-type DC, they may serve as a
starting point from, which to proceed toward an
optimized culture protocol.
Future prospects for such cells are evident. Some
involve the establishment of in-vitro systems to
mimick the tolerogenizing properties of the oral
mucosa, which might be employed in the treatment of
autoaggression. Others may allow a more specific
investigation or treatment of mucosal-based immuno-
pathologic disorders, such as the chronic inflamma-
tory bowel diseases.
MATERIALS AND METHODS
Isolation and Culture of Monocytes
Buffy coats from healthy donors were kindly provid-
ed by the Blood Bank of the University Clinics and
suspended 1:1 in phosphate-buffered saline (PBS)
without Ca
2+ and Mg
2+ (Flow, Meckenheim, FRG).
The suspensions were centrifuged through Lympho-
prep (p 1.077 g/ml; Nycomed, Oslo) at 800 g for
20 rain at RT. Interphases containing peripheral blood
mononuclear cells (PBMNL) were collected and
washed several times with cold PBS to remove
platelets. PBMNL were then suspended in RPMI
1640 (Biochrom, Berlin), supplemented with 2 mM
L-glutamine (Biochrom), and 100 U/ml penicillin
plus 100 U/ml streptomycin (Pen/Strep; Flow) at 5%
normal human serum (NHS).
Five-milliliter volumes of 2.5 107 cells were
placed in hydrophobic 50-mm Teflon Petriperm dish-
es (Bachhofer, Reutlingen, FRG), precoated with
human plasma that was obtained from whole blood
preparations. The PBMNL were incubated for adher-
ence under occasional agitation. After 40-45 rain,
nonadherent cells were rinsed off, and successful
enrichment of monocytes (> 95%) was verified
microscopically. On average, 10% of the initial cell
suspension was adherent under these conditions, that
is, --2.5 106 monocytes remained per culture dish.
Monocytes were then added fresh RPMI 1640 with
Pen/Strep and 5% NHS, containing GM-CSF (100
IU/ml), IL-4 (100 IU/ml), and IFN-y (50 IU/ml)
(Genzyme, Cambridge, UK). The cells were incubat-
ed for 6 days to differentiate into MoDC. Monocytes
were also cultured without cytokines.
For phenotypical and functional analyses, freshly
isolated monocytes or adherent cells in culture were
detached by 1-hr incubation with cold PBS/0.01%
EDTA. Suspended cells were collected as well. After
several washes at 350 g in the cold, cells were
adjusted to concentrations detailed in the respective
method.
The viability of enriched monocytes or cultured
cells was determined with propidium iodide at 5 mg/
ml. The substance intercalates with cellular DNA
when infiltrating dead or damaged cells. Incubated
cells were immediately analyzed flow-cytometrically
for red fluorescence (I 570 nm) of nuclei. General
viability was > 95%; occasional cultures exhibiting
lower viability rates were excluded from the
experiments.GENERATION OF MATURE HUMAN DC 35
Isolation, Pooling, and Storage of T Cells
Sheep blood was diluted 1:1 with PBS (RT) and
washed several times for 12 min at 1630 g and RT.
The erythrocyte pellet was then suspended in RPMI
1640 and stored overnight at 4C. Red cells were
used for CD2-dependent rosetting of T cells. To
enhance erythrocyte-T-cell interaction, nonadherent
PBMNL were washed and suspended at 2 107/ml
in 1% (w/v) polyethylene glycol dissolved in RPMI
1640/5% NHS. The suspension was then added 10%
(v/v) erythrocyte solution.. Cells were carefully
mixed, sedimented for 10 min at 350 g, and T-cell
rosetting was carried out for hr in the dark at 4C.
Successively, pellets were carefully resuspended with
12 ml PBS (RT) to preserve rosettes, layered onto
Lymphoprep gradients, and centrifuged for 18 min at
800 g. While discarding the supernatant and
nonrosetted interphase cells, pelleted T-cell eryth-
rocyte rosettes were resuspended in PBS and washed
three times. Rosettes were then suspended in 5-10 ml
erythrocyte lysis buffer (Gieseler et al., 1991) and
incubated for 15-30 min at 37C. Thereafter,
T lymphocytes were obtained by several washes to
remove red-cell debris. T-cell’s viability was > 95%
in all of the cases, as determined by trypan blue
exclusion.
To employ T cells as allogeneic MLC responder
cells, we prepared T-cll pools from four to six
donors. Aliquots of 2.5 107 T cells per 450 /xl
FCS (PAA Biologics, Marburg, FRG) were then
portioned into precooled cryotubes (Nunc, Wiesba-
den, FRG). Immediately after adding 50 /xl DMSO
each, the tubes were frozen to-70C at 1-2C/min.
Pools were used no later than 30 days after storage.
Viability of thawed T-cell pools, as determined by
trypan blue exclusion, was --90%.
Scanning Electron Microscopy
To preserve general cell morphology and veil
expression, we avoided time-consuming preparatory
steps and physical alterations. Round 8-mm cover-
slips were precoated with 0.01% poly-L-lysine in
deionized water and covered with droplets of 2%
glutaraldehyde in 0.1 M cacodylate buffer. Non-
adherent monocyte-derived veiled cells were then
carefully collected from cultures with a Pasteur
pipette, and concentrated in the pipette tip by 1-g
sedimentation. Small volumes of cell suspension
were applied on top of the glutaraldehyde droplets.
Thus, the cells were carefully fixed while sediment-
ing, and were successively immobilized on the poly-
i-lysine-coated glass surface. The fixative was
removed after 2 hr. After dehydration in graded
ethanol, samples were dried in a critical point dryer
(Polaron, Watford, UK), mounted on stubs, and coat-
ed with gold/palladium in a cool sputter coater
(Fisons Instruments, Uckfield, UK). Micrographs
were taken with a DSM 960 scanning electron micro-
scope (Zeiss, Oberkochen, FRG).
Flow Cytometry
All steps were carried out at 4C. Monoclonal anti-
bodies (mAb) used are given in Table I. Adherent and
suspended cells were collected and transferred to
96-well round-bottom microtiter plates (Nunc) at
105 cells/100 /xl. To keep all cells suspended,
wells were precoated for 30 min with 200/xl block-
ing buffer (10% heat-inactivated rabbit serum and
0.1% NaN3 in PBS). Cells were sedimented and
incubated for 30-45 min in blocking buffer.
For direct staining, each well received 5 #1 of
phycoerythrin- (PE) conjugated anti-CD64 (1:10 in
washing buffer, i.e., 1% BSA and 0.1% NaN3 in
PBS). For direct double staining (CDla fluores-
cein isothiocyanate [FITC], CD3 PE, CD19
PE, CD71 FITC), the cells were resuspended in
50 /xl washing buffer, and were added 5 /xl of PE
conjugate plus 5 /xl of FITC conjugate. The plates
were incubated for 45 min, and washed thereafter.
For storage of up to 2 days, stained cells were fixed
with 200 #l/well of 1% formaldehyde in PBS, sealed,
and stored in the dark.
All other antigens (cf. Table I) were stained
indirectly, by either adding 50 /A/well of first mAb36 R. GIESELER et al.
TABLE Mouse Anti-Human mAb Used for the Flow-Cytometric Characterization of Monocyte-Derived DC
CD Other names Clone Isotype Source
CDla OKT6 (SK9) IgG1 Ortho
CD11a LFA- ce 25.3.1 IgG Immunotech
CD lb CR3, Mac- ce BEAR1 IgG1 Dianova
CD 11c p150/90- ce BU-15 IgG Immunotech
CD14 Hb44 (63D3) IgG1 ATCC
CD16a FcTR IliA CLB-149 IgG2a Janssen
CD18 LFA- 1/3 BL5 IgG Dianova
CD32 FcyR II 2El IgG2a Dianova
CD33 WM54 IgG Serotec
CD40 EA-5 IgG1 Serotec
CD45R0 PTP isoform UCHL1 IgG2a Serotec
CD50 ICAM-3 KS128 IgG Dako
CD54 ICAM- 84H10 IgG Immunotech
CD64 FcyR 10.1 IgG PharMingen
CD68 EBM 11 IgG Dako
CD71 TfR YDJ1.2.2 IgG Immunotech
CD80 B7-1 MAB 104 IgG Dianova
CD86 B7-2 BU-63 IgG1 Serotec
HLA-A,B,C Hb95 (W6/32) IgG2a ATCC
HLA-DR B8.12.2 IgG2b Immunotech
HLA-DP B7/21 IgG1 Becton-Dickinson
HLA-DQ SK 10, IgG Becton-Dickinson
aB7-1, costimulatory ligand for CD28 and CTLA-4; CR3, complement receptor type 3; FcyR I, II, and IliA, Fc receptors for IgG; gp45,
member of the integrin superfamily; HLA-A, -B, -C, MHC class antigens; HLA-DR, -DP, -DQ, MHC class II antigens; ICAM-1 and -3,
intercellular adhesion molecules and 3; LFA-1 ce and -1/3, leukocyte function-associated antigen eeL- and/3-chain; Mac-1 ce, integrin ceM-
chain; pl50/90-ce, integrin Cex-chain; PTP, protein tyrosin phosphatase (a.k.a. leukocyte common antigen, T200); TfR, transferrin
receptor.
(1:50 in washing buffer) or 100/A/well of undiluted
hybridoma supernatant per well. After an incubation
for 45 min in the dark, the plates were centrifuged,
depleted of antibody solution, washed twice, and
supplied with 50/zl/well of 1:50 second rabbit anti-
mouse IgG F(ab’)2 PE (Dianova, Hamburg). The
plates were again incubated for 45 min in the dark,
and final processing was as described earlier.
Negative controls for direct staining employed
irrelevant mouse IgG1 FITC or murine IgG2a
PE (Dianova). Nonsense mouse anti-human IgG
TIB-8 hybridoma supernatant (ATCC, Rockville,
MD) was used as a negative control for indirect
staining.
Cellular antigen expression was measured with the
FACStar
l’IUs Type IV (Becton-Dickinson, Erembo-
degem-Aalst, Belgium). FITC-conjugated mAb were
detected at A 530 nm, whereas PE conjugates were
measured at A 570 nm. Cell fragments were
excluded by adjusting the particle-size threshold.
Occasional autofluorescence was subtracted from the
respective determinations. Data were then evaluated
with the C30 calculation program (Becton-Dickin-
son), resulting in percentages of antigen-positive cells
per specimen, as well as mean fluorescence intensi-
ties (AMFI), which were determined using the sub-
tract-graph option according to Werfel et al.,
(1991).
AMFI MFIsAM,LE MFIcorqTRoi (1)
Controls for T cells (anti-CD3; UCHT1, IgG1;
Immunotech), B cells (anti-CD19, J4.119, IgG1;
Immunotech), NK cells (anti-CD56, B-A19, IgG1;
Serotec), and granulocytes (anti-CD66, 80H3, IgG1;GENERATION OF MATURE HUMAN DC 37
Immunotech) were negative in all of the cases (not
demonstrated).
Allogeneic One-Way MLC
MLC tests were run in 96-well flat-bottomed micro-
titer plates (Nunc). Cells detached from Teflon dishes
were adjusted to 2 105/ml in RPMI 1640 plus 10%
FCS. Stimulator cells were then plated at 6.25 102
to 2 104 per well, irradiated at 1500 rad, and
coincubated with 2 105/well allogeneic responder
T cells (pretested for reactivity). Negative controls
omitted responders or stimulators. After 5 days, each
culture well was added 1.0/xCi (37 kBq) of [3H]thy-
midine (Amersham, Braunschweig, FRG), and the
tests were stopped 24 hr later. Cells were then har-
vested using an automated Inotech cell harvester
(Dunn, Asbach, FRG), and thymidine incorporation
was determined with a Matrix 96 Direct /3 Counter
(Hewlett-Packard, Meriden, CT). Results are
expressed as [dpm].
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